Complete clearance of severe plaque psoriasis with 24 weeks of oral roflumilast therapy
暂无分享,去创建一个
[1] C. Griffiths,et al. Clinical characteristics, symptoms and burden of psoriasis and atopic dermatitis in adults , 2020, The British journal of dermatology.
[2] B. Strober,et al. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies , 2020 .
[3] B. Strober,et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. , 2019, Journal of the American Academy of Dermatology.
[4] D. Jayne,et al. SUMMARY OF PRODUCT CHARACTERISTICS , 2014 .
[5] C. Thongprayoon,et al. Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis , 2016, The Journal of dermatological treatment.
[6] L. Kong,et al. Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis , 2015, PloS one.
[7] S. Yadav,et al. Nutrition in chronic obstructive pulmonary disease: A review , 2015, Journal of translational internal medicine.
[8] Nicola M. Walsh. Comparison of the modes of action of Apremilast and Roflumilast , 2015 .